Correspondence 0001437749-23-007070 from Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685) (VTGN)
Vistagen Therapeutics, Inc. (VTGN) (CIK 0001411685)
Date: March 17, 2023 · CIK: 0001411685 · Accession: 0001437749-23-007070
AI Filing Summary & Sentiment
File numbers found in text: 333-270232
Letter
VIA EDGAR United States Securities and Exchange Commission Attention: Tyler Howes Vistagen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-270232)
RE:
Dear Mr. Howes,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, Vistagen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 4:00 p.m. Eastern Standard Time on Tuesday, March 21, 2023, or as soon as practicable thereafter.
Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Mr. Daniel Rumsey at (619) 272-7062, to confirm the exact time at which the Registration Statement was declared effective.
Very truly yours,
VISTAGEN THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm vtgn20230316_corresp.htm March 17, 2023 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes RE: Vistagen Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-270232) Dear Mr. Howes, Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, Vistagen Therapeutics, Inc., a Nevada corporation (the “Registrant”), hereby requests acceleration of the effective date of the Registration Statement referred to above so that it may become effective at 4:00 p.m. Eastern Standard Time on Tuesday, March 21, 2023, or as soon as practicable thereafter. Upon grant of our request to accelerate effectiveness, we would appreciate your communicating with our counsel, Disclosure Law Group, a Professional Corporation, by calling Mr. Daniel Rumsey at (619) 272-7062, to confirm the exact time at which the Registration Statement was declared effective. Very truly yours, VISTAGEN THERAPEUTICS, INC. /s/ Shawn K. Singh Shawn K. Singh Chief Executive Officer cc: Daniel W. Rumsey Disclosure Law Group, a Professional Corporation